Sanofi »

Odyssey Therapeutics shares owned by Sanofi

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Sanofi from 13F filings

Historical chart of Sanofi investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Sanofi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Sanofi

Quarter filed Position value Share count Share price at filing
2026-06-30 $37M 2.0M 18.71

More positions owned by Sanofi

Meiragtx Holdings (MGTX)
Inhibrx Biosciences (INBX)
Novavax Com New (NVAX)
Anaptysbio Inc Common (ANAB)
Odyssey Therapeutics Common Stock
Agomab Therapeutics NV Sponsored Ads (AGMB)
Maplight Therapeutics (MPLT)
First Tracks Biotherapeutics Ord Shs (TRAX)
Immuneering Corp Class A Com (IMRX)
Q32 Bio (QTTB)

View all positions for Sanofi

Top funds holding Odyssey Therapeutics

Sanofi
Standard Life Aberdeen
TD Asset Management

View all funds holding Odyssey Therapeutics